Bayer Aktiengesellschaft (LON:0P6S)

Market Cap	34.36B +74.2%
Revenue (ttm)	39.76B -2.2%
Net Income	-3.16B
EPS	-3.21
Shares Out	n/a
PE Ratio	n/a
Forward PE	9.51
Dividend	0.09 (0.23%)
Ex-Dividend Date	Apr 28, 2025

Volume	188,629
Average Volume	1,335,847
Open	39.79
Previous Close	39.48
Day's Range	39.59 - 40.18
52-Week Range	18.37 - 49.78
Beta	0.93
RSI	51.56
Earnings Date	Mar 4, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge...

• Industry: Chemicals and Allied Products
• Founded: 1863
• Employees: 87,280
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0P6S

Financial Performance

In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.

Financial numbers in EUR